STAAR Surgical Company (NASDAQ:STAA) Q4 2024 Earnings Call Transcript
February 11, 2025 5:00 PM ET
Company Participants:
Brian Moore – VP, Investor Relations and Corporate Development
Tom Frinzi – Chair of the Board, President, and CEO
Patrick Williams – CFO
Conference Call Participants:
Iseult Mcmahon – BTIG
Tom Stephan – Stifel
Anthony Petrone – Mizuho
Macauley Kilbane – William Blair
Patrick Wood – Morgan Stanley
Steve Lichtman – Oppenheimer
Jim Sidoti – Sidoti & Co.
Phillip Dantoin – Piper Sandler
Jon Young – Canaccord
David Saxon – Needham & Co.
Mason Carrico – Stephens
Operator: Greetings and welcome to the STAAR Surgical Fourth Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today, Tuesday, February 11th, 2025.
STAAR Surgical Company (NASDAQ:STAA) recently held its Q4 2024 earnings call, where key executives shared insights into the company’s financial performance and strategic initiatives for the future. Tom Frinzi, the Chair of the Board, President, and CEO, discussed the company’s strong fourth-quarter results and outlined plans for continued growth. Patrick Williams, the CFO, provided detailed financial analysis and projections for the upcoming quarters.
The conference call was attended by various analysts and investors, including representatives from BTIG, Stifel, Mizuho, and more. This diverse group of participants asked insightful questions and engaged in discussions about STAAR Surgical’s market position and potential opportunities in the industry.
Overall, the Q4 2024 earnings call highlighted STAAR Surgical’s commitment to innovation, financial strength, and growth prospects. The company’s leadership team remains optimistic about the future and is focused on delivering value to shareholders and customers alike.
How will this affect me?
As a current or potential investor in STAAR Surgical Company (NASDAQ:STAA), the insights shared during the Q4 2024 earnings call can help you make informed decisions about your investment portfolio. Understanding the company’s financial performance and strategic direction can guide your investment strategy and provide valuable insights into potential risks and opportunities.
How will this affect the world?
STAAR Surgical Company’s continued success and growth have the potential to positively impact the world by advancing medical technology and improving vision care for individuals globally. The company’s innovative products and solutions contribute to enhancing healthcare outcomes and quality of life for patients around the world.
Conclusion:
The STAAR Surgical Q4 2024 earnings call provided valuable insights into the company’s performance and strategic direction. With a focus on innovation, financial strength, and growth, STAAR Surgical is well-positioned to make a positive impact on the industry and global healthcare landscape.
